The Home Place At Midway in Midway, KY

The Home Place At Midway is a medicare and medicaid certified nursing home in Midway, Kentucky. It is located in Woodford county at 101 Sexton Way, Midway, Kentucky 40347. You can reach out to the office of The Home Place At Midway via phone at (859) 846-4663. This skilled nursing facility has 23 federally certified beds with average occupancy rate of 125.65%. The nursing facility is classified as "Continuing Care Retirement Community" by CMS and its legal business name is The Homeplace At Midway Inc and has the following ownership type - Non Profit - Church Related.

The Home Place At Midway (Medicare CCN 185479) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2016 (8 years certified) and the last quality survey was conducted in July, 2019.

Name	The Home Place At Midway
Location	101 Sexton Way, Midway, Kentucky
Certified By	Medicare and Medicaid
No. of Certified Beds	23
Occupancy Rate	125.65%
Medicare ID (CCN)	185479
Legal Business Name	The Homeplace At Midway Inc
Ownership Type	Non Profit - Church Related

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with The Home Place At Midway from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for The Home Place At Midway are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care The Home Place At Midway give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Phase III trial results of lixisenatide for type 2 diabetes presented at 46th EASD

Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.

Kirigami shoe grips could help reduce risk of falling among older adults

You've never seen a pair of snake skin shoes like this before.

Men may connect strongly to publicity campaigns about depression and suicide

A recent study revealed that men might connect strongly to publicity campaigns about depression and suicide, particularly when they have options for anonymous help. In Regensburg, Germany, a two-year intervention campaign resulted in a marked drop in male suicides.

NIH awards $2.1 million grant to counter antibiotic resistance in Gram-negative bacteria

The National Institutes of Health has awarded Dr. Walter Fast, associate professor of medicinal chemistry at The University of Texas at Austin's College of Pharmacy, a four-year $2.1 million grant to develop small-molecules that counter antibiotic resistance in Gram-negative bacteria. If successful, the research could lead to new drugs for treating bacterial infections that are resistant to most antibiotics.

Read more Medical News

› Verified 4 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of The Home Place At Midway is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	13.04	14.46
Percentage of long-stay residents who lose too much weight	1.41	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	41.67	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	0	1.79
Percentage of long-stay residents with a urinary tract infection	1.09	2.65
Percentage of long-stay residents who have depressive symptoms	1.08	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	9.47	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	100	93.87
Percentage of long-stay residents who received an antipsychotic medication	15.79	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	100	83.88